Cargando…
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
Hepatocellular carcinoma (HCC) is one of most common cancers and the fourth leading cause of death worldwide. Commonly, HCC development occurs in a liver that is severely compromised by chronic injury or inflammation. Liver transplantation, hepatic resection, radiofrequency ablation (RFA), transcath...
Autores principales: | Leone, Patrizia, Solimando, Antonio Giovanni, Fasano, Rossella, Argentiero, Antonella, Malerba, Eleonora, Buonavoglia, Alessio, Lupo, Luigi Giovanni, De Re, Valli, Silvestris, Nicola, Racanelli, Vito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160723/ https://www.ncbi.nlm.nih.gov/pubmed/34065489 http://dx.doi.org/10.3390/vaccines9050532 |
Ejemplares similares
-
Actors on the Scene: Immune Cells in the Myeloma Niche
por: Leone, Patrizia, et al.
Publicado: (2020) -
Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis
por: Fasano, Rossella, et al.
Publicado: (2022) -
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs
por: Leone, Patrizia, et al.
Publicado: (2019) -
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice
por: Buonavoglia, Alessio, et al.
Publicado: (2021) -
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis
por: Solimando, Antonio Giovanni, et al.
Publicado: (2021)